Q32 Bio (QTTB) Stock Forecast and Price Target 2025 - MarketBeat

6 days ago · Enter your email address to receive the latest news and analysts' ratings for Q32 Bio and its competitors. ... Reiterated Rating: Outperform Market Perform: $68.00 $9.00-63.13%: ... 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Q32 Bio in the last twelve …

13%
OFF

Q32 Bio (QTTB) Stock Forecast And Price Target 2025 - MarketBeat

2 weeks from now

marketbeat.com

$9.00
OFF

Q32 Bio's (QTTB) "Outperform" Rating Reiterated At Raymond James

2 weeks from now

Dec 11, 2024 · Leerink Partners reaffirmed a "market perform" rating and set a $9.00 target price (down from $68.00) on shares of Q32 Bio in a report on Wednesday. Finally, Piper Sandler cut …

marketbeat.com

$9.00
OFF

Q32 Bio Inc. (NASDAQ:QTTB) Given Consensus ... - ETF Daily News

2 weeks from now

Dec 25, 2024 · Leerink Partners restated a “market perform” rating and issued a $9.00 target price (down previously from $68.00) on shares of Q32 Bio in a research note on Wednesday, …

etfdailynews.com

8%
OFF

Q32 Bio Inc. (NASDAQ:QTTB) Short Interest Up 55.8% In December

2 weeks from now

Dec 30, 2024 · Q32 Bio Inc. (NASDAQ:QTTB – Get Free Report) was the recipient of a large increase in short interest during the month of December. ... Leerink Partners reiterated a …

americanbankingnews.com

19%
OFF

Q32 Bio Inc. (QTTB) Stock Price, Quote & News - Stock ... - Stock …

2 weeks from now

1 day ago · According to 8 analysts, the average rating for QTTB stock is "Buy." The 12-month stock price forecast is $29.14, which is an increase of 849.19% from the latest price. ... Q32 …

stockanalysis.com

$18.46
OFF

Q32 Bio (NASDAQ:QTTB) Receives Market Perform Rating From …

2 weeks from now

Dec 11, 2024 · Check Out Our Latest Stock Analysis on Q32 Bio. Q32 Bio Trading Down 75.6 %. Shares of Q32 Bio stock traded down $18.46 on Wednesday, reaching $5.95. 3,394,429 …

marketbeat.com

$68.00
OFF

Positive Outlook For Q32 Bio: Buy Rating Backed By Promising …

2 weeks from now

Nov 11, 2024 · Thomas Smith, an analyst from Leerink Partners, reiterated the Buy rating on Q32 Bio (QTTB – Research Report). The associated price target is $68.00. The associated price …

businessinsider.com

$3.70
OFF

FY2025 EPS Estimates For Q32 Bio Raised By Leerink Partnrs

2 weeks from now

Dec 14, 2024 · Get Our Latest Research Report on QTTB. Q32 Bio Price Performance. Q32 Bio stock opened at $3.70 on Friday. The company has a debt-to-equity ratio of 0.61, a quick ratio …

etfdailynews.com

$20
OFF

Q32 Bio Price Target Lowered To $20 From $80 At Oppenheimer

2 weeks from now

Dec 11, 2024 · Oppenheimer lowered the firm’s price target on Q32 Bio (QTTB) to $20 from $80 and keeps an Outperform rating on the shares. The firm notes Q32 Bio reported negative AD …

nasdaq.com

$8478000
OFF

Q32 Bio (NASDAQ:QTTB) Rating Lowered To Hold At Leerink Partnrs

2 weeks from now

Dec 12, 2024 · Eventide Asset Management LLC bought a new stake in shares of Q32 Bio in the 3rd quarter valued at about $8,478,000. Harvard Management Co. Inc. acquired a new stake …

marketbeat.com

$3.10
OFF

Q32 Bio Stock Price Today (NASDAQ: QTTB) Quote, Market Cap, …

2 weeks from now

2 days ago · With Q32 Bio stock trading at $3.10 per share, the total value of Q32 Bio stock (market capitalization) is $37.76M. Q32 Bio stock was originally listed at a price of $335.88 in …

wallstreetzen.com

FAQs about Q32 Bio (QTTB) Stock Forecast and Price Target 2025 - MarketBeat Coupon?

Should you buy q32 Bio Inc (qttb)?

Shares of Q32 Bio Inc. (NASDAQ:QTTB – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eight research firms that are currently covering the firm, MarketBeat.com reports. Four research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average […] ...

How many insiders own q32 bio (QTb) stock?

In the past three months, Q32 Bio insiders have not sold or bought any company stock. 16.10% of the stock of Q32 Bio is held by insiders. A high percentage of insider ownership can be a sign of company health. Only 31.32% of the stock of Q32 Bio is held by institutions. Receive QTTB Stock News and Ratings via Email ...

Is q32 bio a good buy?

The updates in the clinical timelines, coupled with an increased probability of success for bempikibart based on positive data from related studies, have led to an increased price target from $54 to $68. These factors underpin the Buy rating, indicating strong momentum and the potential for Q32 Bio to succeed in high-value indications. ...

How much does q32 bio (q32) earn per share?

The consensus estimate for Q32 Bio’s current full-year earnings is ($12.20) per share. Leerink Partnrs also issued estimates for Q32 Bio’s FY2026 earnings at ($3.11) EPS, FY2027 earnings at ($3.62) EPS and FY2028 earnings at ($2.50) EPS. Other equities research analysts have also recently issued research reports about the company. ...

How do I receive news & ratings for q32 bio?

Receive News & Ratings for Q32 Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Q32 Bio and related companies with MarketBeat.com's FREE daily email newsletter. This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team... ...

Who owns q32 bio?

Top institutional shareholders of Q32 Bio include FMR LLC (3.50%), Eventide Asset Management LLC (1.56%), Geode Capital Management LLC (1.08%) and State Street Corp (0.90%). How do I buy shares of Q32 Bio? Shares of QTTB stock can be purchased through any online brokerage account. ...